Genetic determinants excluding GBCR::ABL
mutations of imatinib mesylate therapy
response among chronic myeloid
leukaemia patients in Malaysia

QR Code

Genetic determinants excluding GBCR::ABL mutations of imatinib mesylate therapy response among chronic myeloid leukaemia patients in Malaysia

Despite imatinib mesylate (IM) being the frontline drug for successful treatment of chronic myeloid leukaemia (CML), a significant proportion of CML patients on IM therapy develop resistance and attain poor outcome. The objective of the present study was to investigate the contribution of selecte...

Full description

Bibliographic Details
Main Author:	Ismail, Siti Mariam
Format:	Thesis
Language:	English
Published:	2023
Subjects:	RC Internal medicine
Online Access:	http://eprints.usm.my/58908/ http://eprints.usm.my/58908/1/SITI%20MARIAM%20ISMAIL%20-FINAL%20THESIS%20S-UD000420%28R%29%2024%20pages.pdf

Similar Items

Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015)

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012)

Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment
by: Asrari, Zaidatul Shakila Mohamad
Published: (2014)

Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019)

Application of high resolution melting (HRM) analysis in detection of PDGFRA gene mutations among chronic myeloid leukemia patients treated with imanitib mesylate
by: Rashid, Nur Sabrina Abd
Published: (2020)

Influence of tert gene expression, telomerase activity and telomere length in relation to imatinib mesylate resistance in Malaysian chronic myeloid leukaemia patients
by: Shamshudin, Wati @ Hayati Mohd
Published: (2020)

Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
by: Chen, Li-Chia, et al.
Published: (2014)

Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah
Published: (2015)

Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy
by: Maddin, Najlaa
Published: (2017)

Molecular basis of primary and secondary resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012)

Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response
by: Ankathil, Ravindran
Published: (2016)

Detection of BCR/ABL gene in chronic Myeloid Leukaemia: comparison of Fluorescence in situ Hybridisation (FISH), conventional Cytogenetics and Polymerase Chain Reaction (PCR) techniques
by: Reena RMZ,, et al.
Published: (2006)

Donor chimerism and bcr-abl gene status following non-myeloablative peripheral blood stem cell transplantation in chronic myeloid leukaemia patients in HUKM
by: Seman, Zainina, et al.
Published: (2008)

FLT3, NPM1, DNMT3a and NRAS genes mutation in acute myeloid leukaemia in HUSM
by: Mat Yunus, Noraini
Published: (2015)

Ultra-high performance liquid chromatography (uhplc) method development and validation for the determination of serum imatinib and its active metabolite concentration among chronic myeloid leukemia patients
by: Liong, Tan Ka
Published: (2013)

Survival rate and prognostic factors of survival among chronic myeloid leukaemia adults after initiation of tyrosine kinase inhibitor therapy in Hospital Ampang, Selangor
by: Ali, Zakiah Bakar
Published: (2024)

C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice
by: Knight, B., et al.
Published: (2008)

Incidence of c-Cbl mutations in human acute myeloid leukaemias in an Australian patient cohort
by: Ghassemifar, Reza, et al.
Published: (2011)

The immunotype of acute leukaemia in Kelantan as determined by flow cytometry
by: Dasgupta, Anil, et al.
Published: (1999)

Use of flowcytometric immunophenotyping in the diagnosis and prognosis of acute leukaemias in Sarawak
by: Voon, Ah Kim
Published: (2004)

Targeting dormancy in acute myeloid leukaemia
by: Doolan, Lara
Published: (2023)

The cytotoxicity effect of ant-444 in human chronic myeloid leukaemia cells (K 562)
by: Khalid, Nor Bahijah, et al.
Published: (2013)

DNA damage response and anti-apoptotic proteins expression in NPMc+ mutated cells in acute myeloid leukaemia
by: Qutob, Haitham
Published: (2014)

Cytogenomic profiling of chronic lymphocytic leukaemia patients using dna microarray
by: Zamri, Wan Norizzati Wan Mohamad
Published: (2021)

The Clinical Significance Of Npm1, Flt3 And Cebpa Gene Mutations In Adult Patients With Acute Myeloid Leukaemia
by: Ul Haq, Izaz
Published: (2020)

Epidermal growth factor receptor (EGFR) mutations are the main oncogenic driver mutation in adenocarcinoma in never-smokers - findings from the emlan study
by: Liam, Chong Kin, et al.
Published: (2012)

Gene Expression Profile And Modulation Of Genetic Pathways In Acute Myeloid Leukaemia T(8;21)
by: Bashanfer, Salem Ali Alsalem
Published: (2013)

Identifying and targeting dormant cells in acute myeloid leukaemia
by: Yu, N.
Published: (2016)

Less utilized prognostic markers in acute myeloid leukaemia
by: Abdullah, Maha
Published: (2016)

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia
by: Mohd Amin, A, et al.
Published: (2023)

Genome-wide analysis for genomic alteration in acute promyelocytic leukaemia
by: Hassan, Rosline
Published: (2017)

Recent advances in diagnosis of acute myeloid leukaemia : a review.
by: Ambayya, Angeli, et al.
Published: (2013)

Proteomic profile of acute myeloid leukaemia: a review update
by: Almaiman, Amer Abdulrahman, et al.
Published: (2016)

Identification of differentially expressed proteins as biomarkers of acute myeloid leukaemia
by: Barantalab, Fatemeh
Published: (2014)

Selection of reference genes for quantitative studies in acute myeloid leukaemia
by: Lee, Cindee, et al.
Published: (2019)

Genotype-phenotype study of tuberous sclerosis complex in selected cohort of Malaysian patients with TSC2 mutations
by: Ismail, Nur Farrah Dila
Published: (2015)

Effects of nicotinamide and nilotinib on telomerase activity and telomere length associated with parp-1 regulation in k562 myeloid cell line
by: Muhammad, Nur Rasyidah
Published: (2023)

Characteristics of epidermal growth factor receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients who developed resistance to first or second generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy through T790M mutation / Vijayan Munusamy
by: Vijayan, Munusamy
Published: (2017)

Influence of gene mutations on inflammation, oxidative stress and endothelial function in patients with familial hypercholesterolaemia / Prof. Dr. Hapizah Mohd Nawawi … [et al.]
by: Mohd Nawawi, Hapizah, et al.
Published: (2010)

Moringa oleifera leaf ethanol extract immunomodulatory activity discriminates between chronic myeloid leukaemia cell line and normal lymphocytes
by: Lawal, Hamza, et al.
Published: (2022)